mRNA Cancer Vaccines and Therapeutics Market
mRNA Cancer Vaccines and Therapeutics Market - Global Industry Assessment & Forecast
#
Pages:
145
Base Year:
2022
Oct - 2024
Format:
Report Code:
VMR-1408
Segments Covered
By
Application Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas
-
By
End User Hospitals & Clinics, Ambulatory Surgical Centers, Research Institutes, Others
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 54.99 Billion |
 Revenue 2030:
|
USD 193.14 Billion |
 Revenue CAGR
(2023 - 2030): |
17.00% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
mRNA Cancer Vaccines and Therapeutics Market Segment Analysis
- mRNA Cancer Vaccines and Therapeutics Application Outlook (Revenue, USD Million, 2018 - 2030)
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- mRNA Cancer Vaccines and Therapeutics End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
-
North America mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- U.S.
- U.S. mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- U.S. mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- U.S. mRNA Cancer Vaccines and Therapeutics Market, by Application
- Canada
- Canada mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- Canada mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- Canada mRNA Cancer Vaccines and Therapeutics Market, by Application
-
Mexico
- Mexico mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- Mexico mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- Mexico mRNA Cancer Vaccines and Therapeutics Market, by Application
-
North America mRNA Cancer Vaccines and Therapeutics Market, by Application
- Europe
-
Europe mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
-
Europe mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- U. K.
- U.K. mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- U.K. mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- U.K. mRNA Cancer Vaccines and Therapeutics Market, by Application
- France
- France mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- France mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- France mRNA Cancer Vaccines and Therapeutics Market, by Application
-
Germany
- Germany mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- Germany mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- Germany mRNA Cancer Vaccines and Therapeutics Market, by Application
-
Italy
- Italy mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- Italy mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- Italy mRNA Cancer Vaccines and Therapeutics Market, by Application
-
Spain
- Spain mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- Spain mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- Spain mRNA Cancer Vaccines and Therapeutics Market, by Application
-
Rest of Europe
- Rest of Europe mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- Rest of Europe mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- Rest of Europe mRNA Cancer Vaccines and Therapeutics Market, by Application
-
Europe mRNA Cancer Vaccines and Therapeutics Market, by Application
- Asia Pacific
-
Asia Pacific mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
-
Asia Pacific mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- China
- China mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- China mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- China mRNA Cancer Vaccines and Therapeutics Market, by Application
- Japan
- Japan mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- Japan mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- Japan mRNA Cancer Vaccines and Therapeutics Market, by Application
-
Germany
- Germany mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- Germany mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- Germany mRNA Cancer Vaccines and Therapeutics Market, by Application
-
India
- India mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- India mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- India mRNA Cancer Vaccines and Therapeutics Market, by Application
-
South Korea
- South Korea mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- South Korea mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- South Korea mRNA Cancer Vaccines and Therapeutics Market, by Application
-
South East Asia
- South East Asia mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- South East Asia mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- South East Asia mRNA Cancer Vaccines and Therapeutics Market, by Application
-
Rest of Asia Pacific
- Rest of Asia Pacific mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- Rest of Asia Pacific mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- Rest of Asia Pacific mRNA Cancer Vaccines and Therapeutics Market, by Application
-
Asia Pacific mRNA Cancer Vaccines and Therapeutics Market, by Application
- Latin America
-
Latin America mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
-
Latin America mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- Brazil
- Brazil mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- Brazil mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- Brazil mRNA Cancer Vaccines and Therapeutics Market, by Application
- Argentina
- Argentina mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- Argentina mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- Argentina mRNA Cancer Vaccines and Therapeutics Market, by Application
-
Rest of Latin America
- Rest of Latin America mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- Rest of Latin America mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- Rest of Latin America mRNA Cancer Vaccines and Therapeutics Market, by Application
-
Latin America mRNA Cancer Vaccines and Therapeutics Market, by Application
- Middle East & Africa
-
Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
-
Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- GCC Countries
- GCC Countries mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- GCC Countries mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- GCC Countries mRNA Cancer Vaccines and Therapeutics Market, by Application
- South Africa
- South Africa mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- South Africa mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- South Africa mRNA Cancer Vaccines and Therapeutics Market, by Application
-
Rest of Middle East & Africa
- Rest of Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market, by Application
- Adeno Carcinomas
- Mucinous Carcinomas
- Adenosquamous Carcinomas
- Rest of Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market, by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Others
- Rest of Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market, by Application
-
Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market, by Application
- North America
Vantage Market
Research | 28-Mar-2022
FAQ
Frequently Asked Question
What is the global demand for mRNA Cancer Vaccines and Therapeutics in terms of revenue?
-
The global mRNA Cancer Vaccines and Therapeutics valued at USD 54.99 Billion in 2022 and is expected to reach USD 193.14 Billion in 2030 growing at a CAGR of 17.00%.
Which are the prominent players in the market?
-
The prominent players in the market are Moderna Therapeutics (US), eTheRNA (Belgium), BioNTech (Germany), CureVac (Netherlands), In-Cell-Art (France), Translate Bio (US), Tiba Biotechnology (US), Argos Therapeutics (US), Sangamo Therapeutics (US), and Ethris (Germany)..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 17.00% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the mRNA Cancer Vaccines and Therapeutics include
- High Growth Prospects in Emerging Markets
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the mRNA Cancer Vaccines and Therapeutics in 2022.
